Company page

Abeona Therapeutics Inc.

Abeona Therapeutics Inc. is a public company traded under the ticker ABEO in the American market, with a market capitalization of approximately $328.9 million. The company focuses on developing gene therapies for severe genetic diseases and conditions. Abeona is committed to advancing innovative treatments to improve patient outcomes.